Received Oct 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
fever; body aches; chills; This spontaneous report was received from a nurse prescriber and refers to an older male patient of unknown age. The patient's medical history, concurrent conditions, concomitant therapies, and drug reactions/allergies were not reported. On approximately August 2025 (reported as about a month ago), the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), administered as prophylaxis (dose, route of administration, lot #, and expiration date were not reported). On unknown date in 2025, the patient experienced fever, body aches, and chills. It was reported that the patient experienced an extended period of fever, body aches, and chills more so than they typically see. The patient sought medical attention, and treatment was given for the events. At the reporting time, the outcome of fever, body aches, and chills was unknown. The causal relationship between the reported events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was unknown. Lot # is being requested and will be submitted if received.
Comments: unknown